• Home
  • Contacts
  • FAQs
  • Careers

Mesoblast

banner5
  • About us
    • Company overview
    • Board of Directors
    • Corporate Governance
      • Role and Composition of the Board
      • Constitution
      • Board Committees and Charters
      • Shareholder Communication
      • Risk Management
      • Code of Conduct
      • Key Policies
    • Partners
  • Products
    • Cardiovascular diseases
    • Diabetes
    • Oncology
    • Eye disease products
    • Orthopedic Diseases
  • Technology
    • Overview
    • Scientific publications
      • Technology
      • Orthopedic
      • Cardiovascular
      • Neurological
  • Clinical trials
    • Overview
    • FAQs
  • Investors
    • Overview
    • Market announcements
    • Presentations
    • Analyst Coverage
    • Webcasts
    • Annual Reports
    • ADR trading
    • Email alerts
    • Shareholder meetings
    • Financial Tear Sheet
  • Newsroom
    • Market Announcements
      • Archives
    • Image downloads
    • Email alerts
    • Contacts

Annual reports

  • 29 October 2012 Printable Version of the 2012 Annual Report Mesoblast Group

  • 24 October 2011 Printable Version of the 2011 Annual Report Mesoblast Group

  • 10 May 2010 Printable version of the 2010 Mesoblast Annual Report

  • 28 October 2009 Printable version of the 2009 Mesoblast Annual Report

  • 17 October 2008 Mesoblast Annual Report

  • 28 September 2007 Mesoblast Annual Report

  • 29 September 2006 Mesoblast Annual Report

  • 14 October 2005 Mesoblast Annual Report

  • Investors
    • Overview
    • Market announcements
    • Presentations
    • Analyst Coverage
    • Webcasts
    • Annual Reports
    • ADR trading
    • Email alerts
    • Shareholder meetings
    • Financial Tear Sheet

    Products

    The American Heart Association estimates 80 million American adults (approximately 1 in 3) have one or more forms of cardiovascular diseases...

    Find out more

    Technology

    Stem cell therapy is emerging as the new paradigm for treating and potentially curing human disease. It involves the use of living cells...

    Find out more

    Clinical trials

    Mesoblast is aiming to produce therapeutics for the treatment of heart conditions, blood vessel diseases of the eyes and legs bone marrow regeneration after cancer...

    Find out more
    • Privacy policy
    • Disclaimer
    • Webmail
    • Sitemap
    Copyright © 2013 Mesoblast | Website design by Mightymedia